Bi Asset Management Fondsmaeglerselskab A Sarepta Therapeutics, Inc. Transaction History

Bi Asset Management Fondsmaeglerselskab A

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$63.15 - $90.42 $461,058 - $660,156	-7,301 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$72.25 - $168.95 $175,639 - $410,717	2,431 Added 49.92%	7,301 $544,000
Q4 2020 Feb 12, 2021	SELL	$125.56 - $178.74 $16,699 - $23,772	-133 Reduced 2.66%	4,870 $830,000
Q3 2020 Nov 09, 2020	SELL	$127.12 - $172.34 $25,169 - $34,123	-198 Reduced 3.81%	5,003 $703,000
Q2 2020 Aug 05, 2020	BUY	$93.0 - $171.7 $483,693 - $893,011	5,201 New	5,201 $834,000
Q1 2020 May 11, 2020	SELL	$82.38 - $131.64 $18,535 - $29,618	-225 Closed	0 $0
Q4 2019 Mar 19, 2020	SELL	$76.53 - $135.58 $40,407 - $71,586	-528 Reduced 70.12%	225 $29,000
Q3 2019 Mar 19, 2020	BUY	$72.81 - $156.91 $54,825 - $118,153	753 New	753 $57,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Bi Asset Management Fondsmaeglerselskab A, based on Form 13F filings with the SEC.

Stay updated on Bi Asset Management Fondsmaeglerselskab A with notifications on news.